Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 126 shares at $141.94 ($18K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Scheduled sale ($18k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |